Previously published studies found negligible anti‐cytokine autoantibody levels [42] or, in contrast, the association of anti‐IFN‐alpha2 antibodies with the post‐COVID‐19 condition, specifically in patients with respiratory symptoms [10]. Here, IFNA2 is linked to COVID-19.